Review Article Aberration in Signal Transduction Pathway in Human T-Cell Leukemia Virus Type I-Infected T Cells by Mori Naoki et al.
Acta Med. Nagasaki 45 : 1-8
Review Article 
Aberration in Signal Transduction Pathway in Human T-Cell 
Leukemia Virus Type I-Infected T Cells
Naoki MORI 1), Masahiro FUJII 2), Naoki YAMAMOTO 1)
1) Department of Preventive Medicine and AIDS Research, Institute of Tropical Medicine, Nagasaki University, Nagasaki 
2) Department of Virology, Niigata University School of Medicine, Niigata, JAPAN
 Adult T-cell leukemia (ATL) is a fatal T-lymphoproliferative 
disorder, and its development is associated with infection by 
human T-cell leukemia virus type I (HTLV-I). The molecular 
mechanism of leukemogenesis has not yet been elucidated. 
However, several studies have suggested that aberrations in 
signal transduction in virus-infected T cells are involved in
the　 development　 of　 the　 disease.　 For　 instance,　 NF-κB/Rel,
AP-1, and Jak/STAT signaling pathways are transiently acti-
vated in normal T cells by growth-signals, whereas they are 
constitutively deployed in HTLV-I-infected T-cell lines. The 
HTLV-I viral transactivator Tax has oncogenic properties, 
and is a key molecule in ATL development. Tax activates
several　 transcription　 factors,　 including　 NF-κB/Rel　 and　 AP-1
in HTLV-I-transformed T-cell lines, and induces the expression 
of STAT proteins. Unlike HTLV-I-transformed T-cell lines, pri-
mary ATL cells express low levels of Tax protein. Nevertheless,
the　 NF-κB/Rel,　 AP-1,　 and　 Jak/STAT　 signaling　 pathways　 in
primary ATL cells are also constitutively activated. Thus, the 
aberration in signal transduction pathway may be a common 
key factor to prolonged survival and proliferation of HTLV-I-
infected T cells in vitro and in vivo, but the mechanisms 
seem to be different. Aberration in signal transduction could 
be targeted for the therapeutic control of HTLV-I-associated 
disease.
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Introduction
 Human T-cell leukemia virus type I (HTLV-I) is the 
causative agent of two diseases; the adult T-cell leuke-
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mia (ATL)"Z), a fatal CD4+ T lymphoproliferative dis-
order, and HTLV-I-associated myelopa.thy/tropical spas-
tic paraparesis3'4), a chronic progressive disease of the 
central nervous system. HTLV-1 is also associated 
with other disorders such as uveitis5), arthropathy6), 
and Sjoren's syndrome'. 
 Only a small proportion (3 to 5%) of individuals in-
fected with HTLV-I develop ATL, about 40 to 50 years 
after the infection'). This long latency suggests that 
multiple genetic events which accumulate in HTLV-I-
infected cells are involved in the development of ATL. 
On the other hand, T-cell transformation mediated by 
HTLV-I appears to involve at least two distinct stages'). 
In the first stage, HTLV-I-infected T cells enter an ini-
tial period of polyclonal proliferation, which is depend-
ent on the growth factor interleukin (IL)-2. In turn, 
these clonally expanded cells become immortalized after 
a few weeks in culture as defined by their continuous 
growth in the presence of IL-2. The second stage of 
T cell transformation usually occurs over a period of 
months to years, during which time a subpopulation 
of immortalized T cells acquire chromosomal abnor-
malities and the capacity for IL-2-independent growth. 
 Unlike most oncoviruses, HTLV-I does not contain a 
viral oncogene. The virus-encoded transactivator, Tax, 
has been the subject of intense investigation. In addi-
tion to its ability to activate HTLV- gene expression, 
Tax can transform primary human T lymphocytes proba-
bly by increasing the expression of a unique set of cel-
lular genes that are involved in T cell proliferation. 
Thus, activation of the specific signal transduction 
pathway by Tax could be critical for the induction of 
ATL by HTLV-I. An understanding of the mechanisms 
involved in Tax activation of cellular gene expression 
should increase our knowledge of how alterations in 
cellular gene expression correlate with cellular trans-
formation. This review will discuss recent advances in 
our understanding of Tax function. In addition, we 
present a possible alternative mechanism involved in
Tax-independent activation of signal transduction path-
way in ATL cells in vivo, which might be involved in 
the late stage of leukemogenesis.
NF-KB/Rel pathway
Regulation of NF-tcB/Rel activation 
 The prototypical nuclear factor (NF)-/cB complex cor-
responds to a heterodimer of the p50 (NF-KB1) and 
Re1A (p65) members of the NF-,cB/Rel family of tran-
scription factors'"'). In addition, this family includes 
RelB, c-Rel, and p52 (NF-/cB2). Prior to activation, NF-
KcB exists in the cytoplasm tightly associated with in-
hibitory proteins, including U-13a and related proteins 
(I/cB/9, 1/,-BE:, P105 [NF-icB1], and p100 [NF-icB2])10-12) 
The activity of NF-/CB is stimulated widely by cytokines, 
oxidative stress, phorbol esters, and viral and bacterial 
infections. Activation of NF-KB is mediated by signal 
transduction cascades, which lead to activation of IKB 
kinases, IKKa and IKK(313-17). These two catalytic subunits 
phosphorylate the I/cBs, a modification of which trig-
gers their ubiquitination and proteolysis, allowing the 
released NF-fcB dimers to enter the nucleus and activate 
target genes]). How IKK is activated by the diverse 
signals remains unknown. Several upstream kinases, 
such as two mitogen-activated protein kinase kinase 
kinases (MAP3K), MEK kinase 1 (MEKK 1) and NF-fc B 
inducing kinase (NIK), have been proposed to serve as 
IKK kinases (IKKKs)19-22). Recent studies have identi-
fied IKK y/NEMO (NF-tcB Essential Modulator) in an 
IKK complex23'24) which is thought to act as a mediator 
that connects IKK proteins with upstream activators.
Mechanisms of Tax action on NF-KB/Rel 
  Through NF-/CB, Tax modulates the expression of sev-
eral cytokines, chemokines, immune receptors, adhesion 
molecules, transcription factors, proto-oncogenes, and anti-
apoptotic genes (Fig. 1). In HTLV-I-infected T-cell lines 
or cells expressing the Tax protein, NF-KB is constitutively 
localized in the nucleus"). Tax in part colocalizes with 
NF-/CB in subnuclear regions that contain specific RNA 
transcripts from a promoter containing NF- k B binding 
sites"-"). Tax has been reported to interact physically 
with many members of the NF-KcB/Rel family". These 
findings suggest that Tax functions as a transcriptional 
cofactor acting cooperatively with NF-KB in the nucleus. 
However, Tax-mediated NF-,cB activation is thought to 
be primarily regulated at the level of NF-tcB nuclear 
translocation31-34). In fact, Tax in the cytoplasm can in-
duce NF-KB nuclear translocation. For example, a Tax
Fig. 1. Tax target and potential transcription factors NF-KB/Rel 
and AP-1.
mutant defective in nuclear localization can still acti-
vate NF-KB-dependent transcription"). A series of con-
vincing studies have shown that Tax induces the 
phosphorylation and degradation of I is B a and I K B /9 , 
suggesting that Tax may induce nuclear translocation 
of NF- k B by acting prior to or at the level of I k B 
phosphorylation3l-34, 36,37) . Resolution of this important 
missing link in the Tax / NF- K B signaling axis was 
achieved in conjunction with the identification of IKK. 
Tax triggers activation of both IKKa38-40) and IKK(338-41), 
and this action requires NIK39.40) and MEKK141). Yamaoka 
et al.") established an IKKy/NEMO-deficient rat fibroblast 
line that fails to constitutively express active forms of 
NF-KB in the presence of Tax. This NF-/CB signaling 
defect could be rescued by overexpression of IKKy / 
NEMO, suggesting that IKKy / NEMO is required for 
the proper assembly of the Tax-responsive IKK com-
plex. Several recent studies have indicated that Tax 
physically interacts with IKKy / NEMO, which facili-
tates the recruitment of Tax to the catalytic subunits 
IKKa and IKK/9 and promotes Tax-mediated activation
of IKK42-44). Recently, Sun and Ballard have proposed two 
models for Tax-directed activation of IKK (Fig. 2)45> 
In the first model, Tax recruits an upstream IKKK to 
the IKK signalsome, which triggers phosphorylation and 
activation of the IKKa and IKK/9. Attractive candidates 
for this Tax-responsive IKKK are MEKK 1 and NIK. In 
the second model, Tax displaces a cellular IKK inhibi-
tor (IKKI) from the holoenzyme, yielding a more favor-
able conformation for IKK autoactivation or for the ac-
tion of a Tax-responsive IKK. Thus, Tax/IKKy interac-
tion may serve as a molecular trigger for IKK activation. 
 Nuclear NF-KB DNA-binding activity, consisting of 
p50 and ReIA (p65), is rapidly induced in Tax-expressing 
cells via a post-translational mechanism"). In contrast, 
DNA-binding complexes composed of c-Rel and/or p52 
are activated with relatively delayed kinetics, suggest-
ing a requirement for de novo protein synthesis32' . 
Consistent with these studies, the c-Rel-containing com-
plexes have also been shown to be the major NF-/cB 
binding complexes in HTLV-I-infected T-cell lines that 
constitutively express high levels of Tax 34,46-49) . Tax-
mediated phosphorylation and degradation of hcB may 
contribute to the early-phase induction of the p50/ReIA 
(p65) heterodimer, while the sustained nuclear expres-
sion of c-Rel heterodimers appears to be mediated by ad-
ditional mechanisms. The genes encoding c-Rel and p52 
are under the transcriptional control of ReIA (p65) 34,50) 
implying that activation of NF-/cB is a prerequisite for 
the late-phase induction of c-Rel/p52 heterodimers.
Fig. 2. Hypothetical schemes for Tax-directed activation of IKK. 
Tax recruits an upstream IKKK to the IKK sugnalsome, which 
triggers phosphorylation and activation of the IKKa and/or 
IKK( catalytic subunit(s). Alternatively, removal of IKKI 
may render the IKKa and/or IKKj3 catalytic subunit(s) more 
susceptible to activation by the upstream Tax-responsive IKKK. 
Attractive candidates for Tax-responsive IKKK are MEKKI and 
NIK. IKK activation triggers subsequent signal transduction cas-
cades that result in hyperphosphorylation of I K Bs, ubiquitina-
tion and degradation by the 26S proteasome. After I,cBs deg-
radation, NF-/cB translocates to the nucleus and activates NF-
/cB-dependent cellular genes.
Constitutive NF-KB/Rel activation in ATL 
 Leukemic cells of ATL patients express very low 
levels of viral genes including Tax, suggesting that 
the expression of viral proteins is not necessary for 
leukemic proliferation at the late stage of the disease. 
However, several genes that can be transactivated by 
Tax are also constitutively expressed in leukemic cells 
of ATL patients, probably by a Tax-independent mecha-
nism. For instance, ATL cells in vivo display surface 
IL-2 receptor a chain (IL-2Ra) and express mRNA for 
cytokines and chemokines including IL-la, IL-6, IL-8, 
tumor necrosis factor /9, and monocyte chemoattractant 
protein-151'. Tax activates the transcription of these cel-
lular genes through the NF- k B binding site (Fig. 1). 
Recently, we found that leukemic cells from ATL pa-
tients in vivo, like HTLV-I-transformed T-cell lines in 
vitro, display a constitutive NF- k B binding activity 
and increased degradation of IKBa 49'. Thus, the NF-K 
B/Rel pathway is activated in leukemic cells of ATL 
patients in vivo, which may account for the persistent 
expression of certain cellular genes. We also noticed 
that the components of the activated NF- k B / Rel in 
primary ATL cells are different from those in HTLV-I-
transformed cell lines expressing Tax in vitro. Gel-shift 
analysis demonstrated that NF-,cB complexes are com-
posed of p50/p50 and p50/RelA (p65) dimers in both 
primary ATL cells and ATL-derived T-cell lines, which 
do not express Tax at all, whereas the complexes con-
sist mostly of p50 / c-Rel in Tax-expressing HTLV-I-
transformed T-cell lines. Our studies suggest that con-
stitutive expression of Tax does not appear to be neces-
sary for maintenance of NF-KB/Rel activation in ATL 
cells in vivo and this activation occurs through a Tax-
independent mechanism, possibly due to activation of a 
different NF-KB subunit.
Role of NF-fcB/Rel in Tax oncoprotein function 
 Several studies have suggested that activation of 
NF-KB/Rel by Tax is essential for the transformation of 
rodent cells and human primary T lymphocytes"-"'. 
Inhibition of NF- k B activity by antisense NF-KB p65 
oligonucleotides interferes with the growth of Tax-
transformed cell lines both in vitro and in vivo56' 
Furthermore, recent experiments conducted with infec-
tious molecular clones of HTLV-I DNA indicate that 
activation of the NF-/c B pathway is critical for the 
immortalization of T cells by HTLV-I57'. Recent results 
obtained with CTLL-2, a mouse IL-2-dependent T-cell 
line, have suggested that NF-/cB activation is the key 
to increasing the survival of HTLV-I-infected T cells. 
CTLL-2 cell lines expressing wild-type Tax or a Tax 
mutant, which is still an activator of NF-KCB, are resis-
tant to apoptosis induced in the absence of IL-258'. On 
the other hand, a Tax mutant, which is inactive for 
NF- k B, enhances apoptosis in the absence of IL-2. 
The molecular mechanism of Tax-induced anti-apoptotic 
pathway could involve Bcl-x,, one of the molecules pro-
tecting cells against apoptosis. We and others have re-
cently demonstrated that Tax upregulates the Bcl-x, 
gene through NF-,cB pathway'"".
AP-1 pathway
Regulation of AP-1 
 The AP-1 complex is formed by three Jun-family 
members (c-Jun, JunB, and JunD) and four Fos-family 
members (c-Fos, FosB, Fra-1, and Fra-2), giving rise to 
a large variety of homo- and hetero-dimers binding to 
the same DNA consensus sequence, and are responsi-
ble for the activation of various target genes involved 
in the control of cell proliferation, tumorigenesis, and 
metastasis","'. A causal role of AP-1 in neoplastic trans-
formation has been demonstrated: a dominant negative 
c-Jun is able to suppress the ras-mediated transforma-
tion'"". In addition, it has been reported that cell lines 
established from c-Jun knock out mice are resistant to 
ras-mediated transformation"). AP- 1 proteins are inactive 
in quiescent cells but are rapidly activated by a variety of 
extracellular stimuli, including growth factors, cytokines, 
and cellular stress signals","'. Activation of AP-1 is regu-
lated at the transcriptional and posttranscriptional level. 
Activation of c-Jun N-terminal kinases (JNK, MAP kinase 
family member), also known as stress-activated protein 
kinases (SAPKs), phosphorylates c-Jun at Ser 63 and 
Ser 73 within the N-terminal activation domain, and 
stimulates its transcriptional activity70-72'. The stimulation 
of transcriptional activity of c-Jun after phosphorylation 
appears to be due to a higher affinity for the co-activator 
CBP. In addition, the phosphorylation of c-Jun by JNK 
reduces ubiquitination and degradation, thereby in-
creasing its stability").
Increase in AP-1 activity is a general event at a late 
stage in T-cells transformed by HTL V-I 
 T-cell lines transformed by HTLV-I express high lev-
els of mRNA encoding c-Fos, Fra-1, c-Jun, JunB, and 
JunD74,77', and have high levels of AP-1 activity"-"). Some 
of these genes are induced by Tax747880'. Indeed, Tax 
activates several cellular genes via an AP-1-like site (Fig. 
1). Recently, we analyzed the AP-1 activity in periph-
eral leukemic cells from ATL patients. All fresh periph-
eral blood leukemic cells prepared from eleven patients 
exhibited increased AP-1 activity containing JunD, while 
the activity was not increased in normal peripheral 
blood mononuclear cells"). JunD homodimer generally 
forms unstable complexes with DNA","). However, our 
gel-shift analysis indicated that none of the characterized 
Fos family members (c-Fos, FosB, Fra-1, or Fra-2) was 
included in AP-1 binding complex of primary ATL 
cells. Thus, a factor, different from any currently char-
acterized AP-1 transcription factor, is likely to be a 
component of the AP-1-binding complex in ATL cells. 
In addition to primary ATL cells, all T-cell lines de-
rived from ATL patients also displayed constitutive 
AP-1 activity, but expressed little Tax protein. These 
findings suggest that Tax is not the only mechanism 
for constitutive activation of AP-1 in HTLV-I-infected 
T cells in vitro as well as in vivo. On the other hand, 
the JNK kinase activity was constitutively activated in 
human lymphocytes transformed in vitro by HTLV-I84'. 
Furthermore, such activation occurs only when HTLV-
I-transformed lymphocytes become IL-2 independent. 
However, Tax does not directly activate JNK because 
JNK activation is not observed in cells transfected with 
Tax expression vector. Constitutive JNK activation was 
also detected in leukemic cells of ATL patients. Taken 
together, these findings suggest that the acquisition of 
constitutive JNK activation and subsequent AP-1 acti-
vation represent an important late event in HTLV-I 
leukemogenesis.
Jak/STAT signaling pathway
Inappropriate Jak/S TAT activation in HTL V-I-transformed 
T-cell lines and primary A TL cells 
 The major growth-stimulatory cytokine for T cells is 
IL-2. The IL-2R is composed of at least three chains. 
The a chain is involved in increasing ligand-binding 
affinity, and the /3 and common y (7,) chains are neces-
sary and sufficient for transduction of the IL-2 signal"'. 
IL-2R l9 and yc chains are members of the cytokine re-
ceptor superfamily. None of IL-2R chains has a catalytic 
kinase domain, but like interferon receptors, IL-2R /9 and 
yc chains use the Janus (Jak) family of cytoplasmic tyro-
sine kinases and the signal transducer and activator of 
transcription (STAT) proteins as one important mecha-
nism to transduce their signals. Upon binding of IL-2 to 
its receptor, Jak3 is recruited to the yc chain, while Jakl 
is coupled to the IL-2R/9 chain'"'). These kinases are acti-
vated upon IL-2 signaling") and phosphorylate STAT3, 
STAT5A, and STAT5B proteins","), allowing these pro-
teins to form homo- and hetro-dimers, translocate to 
the nucleus, and bind DNA in a sequence-specific man-
ner to initiate transcription of IL-2 responsive genes. 
Constitutive activation of Jaks and/or STATs is associ-
ated with cell transformation. For instance, in Drosophila, 
dominant activation of Jak leads to malignant neoplasia 
of hematopoietic cells"). Inappropriate activation of 
STAT has been described in many solid and hematologic 
malignancies. The role of Jak/STAT activation has been 
examined in T-cell lines transformed with HTLV-I. Jak1, 
Jak3, STAT3, and STAT5 proteins were constitutively 
activated in some IL-2-independent HTLV-I-transformed 
T-cell lines, whereas no constitutive Jak/STAT activa-
tion was observed in HTLV-I-uninfected T-cell lines and 
IL-2-dependent HTLV-I-transformed ones. Thus, activa-
tion of the Jak/STAT pathway in HTLV-I-transformed 
T-cell lines correlates with the transition from an IL-2-
dependent to an IL-2-independent growth","'. 
 Jak/STAT activation has been examined in primary 
peripheral lymphocytes obtained from ATL patients"). 
Eight out of the twelve patients exhibited constitutive 
tyrosine phosphorylation of STAT proteins as well as 
constitutive STAT binding to the sis-inducible element 
from the c fos promoter and the prolactin responsive 
element from the (9-casein promoter. STAT3 activation 
was found in six patients (50%), and four exhibited 
activation of both STAT3 and STAT1. Activation of 
STAT5 was identified in four patients (33%), and two 
patients (17%) exhibited activation of both STAT3 and 
STAT5. Phosphorylation of Jak3 in leukemic cells was 
associated with activation of STAT3. In contrast, Zhang 
et al.") demonstrated no detectable basal phosphorylation
of Jak3, STAT3, and STAT5 in leukemic cells of all 8 
ATL patients. The reasons for the discrepancy be-
tween these two sets of data are unclear but may be 
related to the relatively small group of samples tested 
(12 and 8, respectively) and/or differences in method-
ology. Recently, experiments by Tsukada et al.9", using 
a probe for the GAS (y interferon activation site)-like 
element termed LILRE (LPS/IL-1-responsive element), 
which is found in the human prolL-1/9 gene, revealed 
constitutive activation of LIL-STAT (LPS/IL-1-induced 
STAT) in all 7 ATL patients, although the precise sig-
nificance of this activation in leukemogenesis remains 
unclear at present.
Mechanism of constitutive activation of Jak/STAT path-
way in HTL V-I-transformed T cells 
 HTLV-I-transformed T-cell lines express higher amounts 
of STAT1, STAT3, and STAT5 mRNA and proteins 
than HTLV-I-negative cells"'. Tax induces the expres-
sion of STAT 1 and STAT5 in a T-cell line, however, it 
does not induce DNA binding activity of these STAT 
proteins and Jak3 activation'"". Indeed, Tax-expressing 
HTLV-I-infected T-cell lines do not always express 
constitutive DNA binding activity of STAT99'. Thus, 
the mechanisms by which HTLV-I transformation in-
duces activation of the Jak/STAT pathway remains to 
be determined. Some HTLV-I-transformed T-cell lines 
such as HUT-102 can produce IL-15100', a T-cell growth 
factor that activates STAT3 and STAT590'. However, 
antibodies against IL-15 do not substantially decrease the 
activation level of Jak/STAT proteins","'. Interestingly, 
conditioned medium from HTLV-I-transformed T-cell lines 
could induce STAT5 activation in HTLV-I-uninfected T-
cell lines (Yamaoka et al., unpublished results). Thus, 
activation of Jak/STAT pathway in HTLV-I-infected cells 
may be due to an autocrine or paracrine stimulation.
Concluding remarks
 In our current model of Tax induced leukemogenesis 
(Fig. 3), Tax causes proliferation of HTLV-I-infected T 
cells by activation of transcription factors including 
NF-/CB and AP-1. Because Tax does not appear to be 
expressed in primary ATL cells, HTLV-I-infected T cells 
with constitutive activation of both NF-/cB and AP-1 
in a Tax-independent manner, are selected during late 
stages of leukemogenesis probably by mutations or al-
terations of cellular genes. This may result in reduced 
requirements of growth factors and may be a crucial 
step in a leukemic proliferation in vivo. The finding that 
ATL cells utilize a variety of mechanisms to activate
Fig. 3. Schematic diagram of hypothesized role of Tax in 
transformation.
several signal transduction pathways suggests that 
such property may be critical for leukemogenesis. We 
are beginning to understand how HTLV-I interacts 
with cellular factors to activate and modulate cellular 
signal transduction pathways leading to the leukemic 
proliferation of virus-infected cells. However, we do 
not know which upstream genetic changes in HTLV-I-
infected cells result in the activation of these signaling 
cascades. Further characterization of these signaling 
cascades in HTLV-I-infected cells in vitro as well as in 
vivo should contribute to our understanding of ATL 
oncogenesis and identify a unique target for the treat-
ment of this unusual leukemia.
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